Valneva appoints dr. hanneke schuitemaker, ph.d. as chief scientific officer

Saint-herblain (france), may 21, 2024 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced the appointment of dr. hanneke schuitemaker, ph.d. as chief scientific officer (cso) and executive committee member, effective june 3, 2024.

VALN Ratings Summary

VALN Quant Ranking